We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current INKT market cap is 34.86M. The company's latest EPS is USD -0.6506 and P/E is -1.49.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.99M | -7.89M | -5.85M | -6.34M | -5.22M |
| Net Income | -6.33M | -7.77M | -5.69M | -6.2M | -5.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.2M | 0 | 0 | 0 | 0 |
| Operating Income | -22.28M | -14.64M | -28.36M | -30.95M | -22.92M |
| Net Income | -23.8M | -16.24M | -30.21M | -27.99M | -22.46M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.26M | 21.47M | 16.59M | 12.11M | 7.46M |
| Total Liabilities | 18.51M | 21.87M | 21.07M | 21.61M | 21.04M |
| Total Equity | 6.76M | -401k | -4.48M | -9.5M | -13.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.31M | 4.56M | 40.24M | 21.47M | 4.55M |
| Total Liabilities | 37.64M | 58.43M | 16.47M | 21.87M | 22.61M |
| Total Equity | -36.33M | -53.87M | 23.78M | -401k | -18.06M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.44M | -18.87M | -4.37M | -8.52M | -12.73M |
| Investing | -122k | -250k | -14k | -51k | -74k |
| Financing | -156k | -155k | -335k | -410k | -408k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.94M | -8.34M | -12.83M | -18.87M | -15.76M |
| Investing | -426k | -95k | -249k | -250k | -74k |
| Financing | 11.44M | 11.11M | 49.26M | -155k | -407k |
| Market Cap | 34.86M |
| Price to Earnings Ratio | -1.49 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.95 |
| Price to Book Ratio | -1.85 |
| Dividend Yield | - |
| Shares Outstanding | 34.52M |
| Average Volume (1 week) | 48.98k |
| Average Volume (1 Month) | 161.28k |
| 52 Week Change | 9.78% |
| 52 Week High | 3.34 |
| 52 Week Low | 0.75 |
| Spread (Intraday) | 0.75 (45.45%) |
| Company Name | MiNK Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://minktherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
